Literature DB >> 1527554

HAM/TSP attributable to blood transfusion.

S Tokudome, H Shibasaki, Y Itoyama, H Shoji, T Nakamura, T Miyoshi, Y Murai, M Ikeda.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1527554      PMCID： PMC489222          DOI： 10.1136/jnnp.55.8.738

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Prevalence of HTLV-I-associated myelopathy among HTLV-I carriers in Saga, Japan.

Authors:  H Shibasaki; S Tokudome; Y Kuroda; T Yanagawa; M Yoshihara
Journal:  Neuroepidemiology       Date:  1989       Impact factor: 3.282

2.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

3.  Blood transfusion and HTLV-I associated myelopathy.

Authors:  M Osame; S Izumo; A Igata; M Matsumoto; T Matsumoto; S Sonoda; M Tara; Y Shibata
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

4.  Estimating attributable risk from case-control studies.

Authors:  A S Whittemore
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321
  5 in total
  1 in total

1.  HTLV-1-associated myelopathy/tropical spastic paraparesis-like rats by intravenous injection of HTLV-1-producing rabbit or human T-cell line into adult WKA rats.

Authors:  S Kushida; M Matsumura; H Tanaka; Y Ami; M Hori; M Kobayashi; K Uchida; K Yagami; T Kameyama; T Yoshizawa
Journal:  Jpn J Cancer Res       Date:  1993-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.